Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Results
Phase 3
This trial compared 3 months with 6 months of chemotherapy for people who had surgery for bowel (colorectal) cancer.
It was for people who had 1 of the following:
cancer that had spread to the (stage 3 bowel cancer)
stage 2 bowel cancer that had a high risk of coming back.
Cancer Research UK supported this trial.
Recruitment start: 27 March 2008
Recruitment end: 29 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tim Iveson
Cancer Research UK
Cancer Research UK Clinical Trials Unit, Glasgow
Oncology Clinical Trials Office (OCTO), Oxford
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC)
NIHR Clinical Research Network: Cancer
Scottish Cancer Research Network
NHS Greater Glasgow and Clyde
University of Glasgow
Danish Colorectal Oncology Group
Vall d’Hebron University Hospital and Institute of Oncology (VHIO)
Universitat Autònoma de Barcelona (UAB)
Australasian Gastro-Intestinal Trials Group (AGITG)
Swedish Society of Gastrointestinal Oncology
Last reviewed: 10 May 2018
CRUK internal database number: 2431
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
